State UT
Clinical Trials in Utah
Utah is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Utah and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 178 actively recruiting studies with Utah sites out of 178 registered in total. The busiest research areas in Utah are Malignant Neoplasm, Advanced Solid Tumor, Heart Failure. Leading sponsors running trials in the state include University of Utah, Eli Lilly and Company, National Cancer Institute (NCI). By stage, Utah trials break down as Phase 1 (30), Phase 2 (47), Phase 3 (49), Phase 4 (6).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Utah
Malignant Neoplasm (3)Advanced Solid Tumor (3)Heart Failure (3)Heart Diseases (3)Cardiovascular Diseases (3)Pulmonary Hypertension (3)Non-Small Cell Lung Cancer (3)Alopecia Areata (2)B Acute Lymphoblastic Leukemia (2)Treatment Resistant Depression (2)Pancreatic Ductal Adenocarcinoma (2)Ischemic Stroke (2)
Frequently Asked Questions — Clinical Trials in Utah
How many clinical trials are currently recruiting in Utah?
ClinicalMetric currently tracks 178 actively recruiting clinical trials with at least one location in Utah. The total number of registered studies—including active but not currently enrolling trials—is 178. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Utah?
Utah hosts clinical trials across a broad range of medical conditions, including Malignant Neoplasm, Advanced Solid Tumor, Heart Failure, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Utah serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Utah?
To join a clinical trial in Utah, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Utah maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Utah
NCT01561157 N/A
Recruiting
Longitudinal Study of the Porphyrias
Condition
Acute Porphyrias
Enrollment
1,500 pts
Location
United States
Sponsor
The American Porphyrias Expert
NCT05678530 N/A
Recruiting
Observational, Non-Interventional Study Supporting Validation of eVO2peak Using ...
Condition
Cardiopulmonary
Enrollment
2,000 pts
Location
United States, Canada
Sponsor
Prolaio
NCT07209111 Phase 2
Recruiting
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (M...
Condition
Neoplasm Malignant
Enrollment
150 pts
Location
United States, Australia, Canada
Sponsor
Merck Sharp & Dohme LLC
NCT04743765 N/A
Recruiting
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
Condition
Hip Fractures
Enrollment
1,100 pts
Location
United States, Australia, Belgium
Sponsor
Population Health Research Ins
NCT06330064 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in ...
Condition
Recurrent or Metastatic Solid Tumors
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Daiichi Sankyo
NCT05267821 Phase 2, Phase 3
Recruiting
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
Condition
Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS)
Enrollment
500 pts
Location
United States
Sponsor
Nationwide Children's Hospital
NCT04510597 Phase 3
Recruiting
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Wi...
Condition
Metastatic Clear Cell Renal Cell Carcinoma
Enrollment
364 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT04600115 EARLY_Phase 1
Recruiting
New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF...
Condition
MRI Scans
Enrollment
100 pts
Location
United States
Sponsor
University of Utah
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
NCT05677880 N/A
Recruiting
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoence...
Condition
CADASIL
Enrollment
660 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT07754461 Phase 3
Recruiting
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Th...
Condition
Type 2 Diabetes
Enrollment
600 pts
Location
United States, Australia, Canada
Sponsor
Boehringer Ingelheim
NCT04142437 N/A
Recruiting
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI Duri...
Condition
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
Enrollment
150 pts
Location
United States, Argentina, Australia
Sponsor
Bayer
NCT03860883 N/A
Recruiting
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Sta...
Condition
Cutaneous Melanoma, Stage II
Enrollment
2,998 pts
Location
United States, Australia, Canada
Sponsor
Melanoma and Skin Cancer Trial
NCT07011732 Phase 3
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the T...
Condition
Alzheimer Disease
Enrollment
426 pts
Location
United States, Argentina, Brazil
Sponsor
Bristol-Myers Squibb
NCT07253285 Phase 3
Recruiting
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Ado...
Condition
Overweight
Enrollment
460 pts
Location
United States, Australia, Austria
Sponsor
Novo Nordisk A/S
NCT07517263 Phase 3
Recruiting
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to E...
Condition
Cardiovascular Disease and Lipoprotein(a)
Enrollment
5,700 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
NCT06848348 Phase 2
Recruiting
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced ...
Condition
Chemotherapy Induced Neuropathic Pain
Enrollment
240 pts
Location
United States
Sponsor
Dogwood Therapeutics Inc.
NCT07136415 Phase 4
Recruiting
Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Ins...
Condition
Menopausal Women
Enrollment
1,000 pts
Location
United States
Sponsor
Brigham and Women's Hospital
NCT06727604 Phase 2
Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatme...
Condition
Graves' Disease
Enrollment
240 pts
Location
United States, Belgium, Georgia
Sponsor
Immunovant Sciences GmbH
NCT07020520 N/A
Recruiting
EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREte...
Condition
Ureteral Stricture
Enrollment
60 pts
Location
United States
Sponsor
Urotronic Inc.
NCT02582697 Phase 3
Recruiting
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poo...
Condition
Germ Cell Tumor
Enrollment
500 pts
Location
United States, Australia, New Zealand
Sponsor
University of Sydney
NCT07198074 Phase 3
Recruiting
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Ca...
Condition
Advanced Endometrial Carcinoma
Enrollment
255 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT03859297 N/A
Recruiting
Mechanisms of Rumination Change in Adolescent Depression
Condition
Major Depressive Disorder
Enrollment
183 pts
Location
United States
Sponsor
Ohio State University
NCT07707115 N/A
Recruiting
Interprofessional Simulation Program for Clinical Resilience and Empathy: Projec...
Condition
Substance Use Disorders
Enrollment
300 pts
Location
United States
Sponsor
University of Utah
NCT07632274 Phase 1
Recruiting
A Study to Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml...
Condition
Pain
Enrollment
12 pts
Location
United States
Sponsor
HALEON
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology